Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Saskia A.G.M. Cillessen, MSc, Wendy J.M. Mackus, PhD, Kitty C.M. Castricum, Wim Vos, Pim C. Kortman, Jan G.J. van de Winkel, PhD, Paul W.H.I. Parren, PhD, Chris J.L.M. Meijer, PhD, MD, Joost J. Oudejans, PhD, MD, (Intr. by Ole Baadsgaard)

Blood (2007) 110 (11): 2346.

https://doi.org/10.1182/blood.V110.11.2346.2346

Published: 2007

Journal Articles

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Saskia A.G.M. Cillessen, MSc, John C. Reed, PhD MD, Clemencia Pinilla, PhD, Chris J.L.M. Meijer, PhD MD, Erik Hooijberg, PhD, Corine J. Hess, MD, Kitty C.M. Castricum, Pim Kortman, Gert J. Ossenkoppele, PhD MD, Joost J. Oudejans, PhD MD

Blood (2007) 110 (11): 803.

https://doi.org/10.1182/blood.V110.11.803.803

Published: 2007

Journal Articles

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Joost J. Oudejans, MD, PhD, Jettie J.F. Muris, MD, Gert J. Ossenkoppele, MD, PhD, Saskia A.G.M. Cillessen, Inge van Houdt, Alain J. Kummer, MD, PhD, Han van Krieken, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Chris J.L.M. Meijer, MD, PhD

Blood (2004) 104 (11): 1544.

https://doi.org/10.1182/blood.V104.11.1544.1544

Published: 2004

Journal Articles

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

Rosita L. ten Berge, Danny F. Dukers, Joost J. Oudejans, Karen Pulford, Gert J. Ossenkoppele, Daphne de Jong, Jo F.M.M. Miseré, Chris J.L.M. Meijer

Blood (1999) 93 (8): 2688–2696.

https://doi.org/10.1182/blood.V93.8.2688

Published: 1999

Journal Articles

HOXC4, HOXC5, and HOXC6 Expression in Non-Hodgkin's Lymphoma: Preferential Expression of the HOXC5 Gene in Primary Cutaneous Anaplastic T-Cell and Oro-Gastrointestinal Tract Mucosa-Associated B-Cell Lymphomas

Janet J. Bijl, Johan W. van Oostveen, Jan M.M. Walboomers, Anja Horstman, Adriaan J.C. van den Brule, Rein Willemze, Chris J.L.M. Meijer

Blood (1997) 90 (10): 4116–4125.

https://doi.org/10.1182/blood.V90.10.4116

Published: 1997

NARROW

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

HOXC4, HOXC5, and HOXC6 Expression in Non-Hodgkin's Lymphoma: Preferential Expression of the HOXC5 Gene in Primary Cutaneous Anaplastic T-Cell and Oro-Gastrointestinal Tract Mucosa-Associated B-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

Chemotherapy-Refractory Diffuse Large B-Cell Lymphomas (DLBCL) Are Effectively Killed by Ofatumumab-Induced Complement-Mediated Cytoxicity.

Small-Molecule XIAP Antagonist Restores Caspase-9-Mediated Apoptosis in XIAP-Positive Diffuse Large B-Cell Lymphoma Cells.

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Adverse Effects of Activated Cytotoxic T Lymphocytes on the Clinical Outcome of Nodal Anaplastic Large Cell Lymphoma

HOXC4, HOXC5, and HOXC6 Expression in Non-Hodgkin's Lymphoma: Preferential Expression of the HOXC5 Gene in Primary Cutaneous Anaplastic T-Cell and Oro-Gastrointestinal Tract Mucosa-Associated B-Cell Lymphomas

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only